Clinical Issues in Patients Treated with Immune Checkpoint Blockade: Challenges and Controversies - 44th Annual Alumni Meeting

Add to Calendar Clinical Issues in Patients Treated with Immune Checkpoint Blockade: Challenges and Controversies - 44th Annual Alumni Meeting 10/17/2019 7:00:00 AM 10/18/2019 5:30:00 PM America/New_York ZRC-AUD false MM/DD/YYYY


Date & Location
Thursday, October 17, 2019, 7:00 AM - Friday, October 18, 2019, 5:30 PM, ZRC-AUD, New York, NY

Specialties
Medical Oncology

Overview
The aim of the two-day program, presented by faculty from Memorial Sloan Kettering (MSK) and invited speakers, is to highlight the debates within the immunotherapy field, and to provide useful insights into ongoing cancer research in the field, and at MSK. Immunotherapy is affecting almost every aspect of patient care in oncology. Yet, the best way to treat patients and manage side effects is often controversial. This educational program will highlight debates within the immunotherapy field and propose best clinical practice patterns based on the latest knowledge.

Objectives
  1. Understand how different types of immunotherapy work
  2. Learn the latest updates in how immunotherapy is used to treat different cancers
  3. Determine how side effects from immunotherapy are best managed
  4. Know when it is appropriate to combine immunotherapy drugs with other treatments
  5. Better understand emerging biomarkers for selecting best candidates for treatment

Registration

To Register, please go to: https://alumni.mskcc.org/alumni-conference  

 

 


Accreditation

Memorial Sloan Kettering Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA Credit Designation Statement

Memorial Sloan Kettering Cancer Center designates this live activity for a maximum of 14 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.